Search

Displaying results 7531 - 7540 of 10000 in total
  1. Drug

    Ulmus rubra pollen

    go.drugbank.com/drugs/DB10985
    Approved

    Ulmus rubra pollen allergenic extract is used in allergenic testing.

  2. Drug

    Bos taurus dander

    go.drugbank.com/drugs/DB11020
    Approved

    Bos taurus dander allergenic extract is used in allergenic testing.

  3. Drug

    Boldo leaf extract

    go.drugbank.com/drugs/DB15815
    ApprovedWithdrawn

    Boldo leaf extract allergenic extract is used in allergenic testing.

  4. Drug

    Myristica fragrans fruit

    go.drugbank.com/drugs/DB15544
    Approved

    Myristica fragrans fruit allergenic extract is used in allergenic testing.

  5. Drug

    Hesperidin

    go.drugbank.com/drugs/DB04703
    ApprovedInvestigational

    Hesperidin is a flavan-on glycoside found in citrus fruits.

  6. Drug

    Tesaglitazar

    go.drugbank.com/drugs/DB06536
    Investigational

    Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. … Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.

  7. Drug

    Clevudine

    go.drugbank.com/drugs/DB06683
    Investigational

  8. Drug

    AI-128

    go.drugbank.com/drugs/DB05841
    Experimental

    AI-128 is the first human demonstration of sustained release drug administration in the lung. … AI-128 consists of slowly dissolving microspheres designed to control where drug particles go in the lung and how quickly they release their drug.

  9. Drug

    Agrostis gigantea top

    go.drugbank.com/drugs/DB14757
    ApprovedWithdrawn

    Agrostis gigantea top is the flowering part of the Agrostis gigantea plant. Agrostis gigantea top is mainly used in allergenic testing.

  10. Drug

    BHV-1300

    go.drugbank.com/drugs/DB22673
    Investigational

    BHV-1300 is a IgG<sub>1,2,4</sub> selective degrader being investigated for the treatment of Grave's disease.